Firmoscan
Active12972395Private limited companyOxford

PLUSULTRA PHARMA UK LTD

Significant control: Jin Shiomura, Aya Iwano (25–50%) and 2 more

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Plusultra Pharma UK Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Plusultra Pharma UK Ltd sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

PLUSULTRA PHARMA UK LTD is an active private limited company (company number 12972395) incorporated on 23 October 2020, registered in Oxford. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2024, showing net assets of £369k and cash of £391k, with 5 employees on average. Net assets fell 29% on the prior period (£518k).

Peer position · net assets

By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).

02

Ownership and control

4 active · 3 other
  • Mr Jin Shiomura
    Individual · since 23 October 2020
    • can appoint or remove directors
  • Ms Aya Iwano
    Individual · since 8 November 2021
    • holds 25–50% of voting rights
  • Ms Kai Shiomura
    Individual · since 8 November 2021
    • holds 25–50% of voting rights
  • Jaksap Pty Ltd
    corporate entity, Australia · since 9 November 2021
    • owns 25–50% of shares
  • Plusultra Pharma Gmbh
    corporate entity, Germany · since 23 October 2020 · ceased 23 October 2020
    • owns 75–100% of shares
  • Mr Takahiro Yamasaki
    Individual · since 23 October 2020 · ceased 23 October 2020
    • can appoint or remove directors
  • Plusultra Pharma Gmbh
    Individual · since 23 October 2020 · ceased 23 October 2020
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
23 October 20206 yrs ago
Next accounts due
30 September 202626 days overdue
Confirmation statement due
6 November 2026in 11 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
SIC 21200
Manufacture of pharmaceutical preparations
SIC 46460
Wholesale of pharmaceutical goods
SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Small
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
£369k
−29%vs Dec 2023
Cash at bank
£391k
−28%vs Dec 2023
Turnover
Not reported
Employees
5
No changevs Dec 2023
Net assets
£369k
Cash at bank
£391k
Average employees
5
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£369k£391k—£463k——5
31 December 2023£518k£544k—£95k——5
Current ratio1.79Current assets ÷ creditors within one year
Cash per employee£78kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £369,223 at 31 December 2024
  • Net assets down 25% or more on the prior period-28.7% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 1.79
  • Cash at bank of £50,000 or moreCash £391,053
  • Incorporated five or more years agoIncorporated 23 October 2020
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 11 days
  2. Next accounts due26 days overdue
  3. Accounts period endNet assets £369k · small accounts
  4. Accounts period endNet assets £518k · small accounts
  5. Incorporated
08

Similar companies in Oxford

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date

All companies incorporated on 23 October 2020 · in Oct 2020.

09

Reminders for PLUSULTRA PHARMA UK LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.

This information comes from public filings and our automated processing of them. It may contain errors, be incomplete or be out of date, and is not advice or a credit reference. Check the official record before relying on it. Terms · Privacy · Report an error (corrected within one working day).